SERI LUGANO Company Profile

17:30 EST 19th January 2019 | BioPortfolio

News Articles [7 Associated News Articles listed on BioPortfolio]

EVOTEC ist schwer einzuordnen!

Schwierig wird die Einordnung der drei Biotech-Titel EVOTEC, MORPHOSYS und QIAGEN. Ihre hohe Bewertung, gemessen an Umsatz und Gewinn, lässt seriöse Berechnungen nicht zu. In der Strategie dieser F....

Innodisk wychodzi na prowadzenie dzięki najszybszej w branży pamięci Wide Temp DDR4

Innodisk wprowadza na rynek serię pamięci DRAM z dużą tolerancją na temperaturę DDR4 2666MT/s w odpowiedzi na zapotrzebowania wydajnościowe najodleglejszych urządzeń w architekturze edge comp...

Micro-Sphere increases capsule filling capacity

The CDMO has installed a MG2 Tekna capsule filling machine in a dedicated cleanroom at its facility in Lugano, Italy

Helsinn Group otorga derechos de licencia exclusiva a Menarini para pracinostat

LUGANO, Suiza y FLORENCIA, Italia, 21 de diciembre de 2018 /PRNewswire/ -- Son derechos de licencia en todo el mundo, con exclusión de EE. UU., Read more...

Helsinn Group verleiht Menarini exklusive Lizenzrechte für Pracinostat

LUGANO, Schweiz und FLORENZ, Italien, December 21, 2018 /PRNewswire/ -- Die Lizenzrechte gelten weltweit mit Ausnahme von den USA, Kanada, Japan und Südamerika. Helsinn, eine Read more...

Le groupe Helsinn accorde des droits de licence exclusifs à Menarini pour le Pracinostat

LUGANO, Suisse et FLORENCE, Italie, December 22, 2018 /PRNewswire/ -- Ces droits de licence sont mondiaux, à l'exception des États-Unis, du Canada, du Japon et Read more...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson & Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition SINGAPORE, Nov. 12, 2018 /PRNewswire/ -- The Singapo...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Clindamycin hydrochloride [Aurobindo Pharma Limited]

Clindamycin Hydrochloride Capsules, USP Rx only

Clindamycin hydrochloride [Preferred Pharmaceuticals, Inc.]

Clindamycin Hydrochloride Capsules, USP Rx only

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

84th annual congress of the Swiss Society of Pathology : November 8-10, 2018, Palazzo dei Congressi, Lugano.

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Anti-PD-1 therapy provides high response rates in Hodgkin lymphoma (HL) patients who have relapsed or are refractory (R/R) to autologous stem cell transplantation (ASCT) and brentuximab vedotin (BV), ...

ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.

The European Society for Medical Oncology (ESMO) consensus conference on malignant lymphoma was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading expert...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

Outcomes of Hallux Valgus Correction Surgery

HV correction surgery using SERI appear to sufficiently reduce the severity of HV deformity in all radiological measurements (HVA, IMA, DMAA) and the correction of subluxation of the first...

SERI® Surgical Scaffold Postmarket Study of Soft Tissue Support and Repair in Breast Reconstruction

Prospective, single center, postmarket clinical study to obtain clinical experience with the use of SERI® Surgical Scaffold for soft tissue support and repair in breast reconstruction.

Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

This study is a multicentric phase II open-label trial consisting of 6 cycles Nivolumab (2 weeks interval) followed by a PET-CT scan. The treatment will be allocated according to PET and C...

Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA

Purpose of the study is the evaluation of the tolerability (both local and systemic) and the clinical efficacy (in terms oocytes recovered) of subcutaneously versus intramuscularly adminis...

PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma

This is an open-label, single-center, nonrandomized, Phase 2 study to evaluate efficacy and safety of SHR-1210 combined with Apatinib in subjects with relapsed or refractory NK/T cell lymp...

Companies [3 Associated Companies listed on BioPortfolio]


Helsinn Healthcare SA

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and subsidiaries in USA and Ireland. Helsinn's unique business model is focused on the licensing of phar...

Helsinn Group and DARA BioSciences, Inc.

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland and the United States. Helsinn’s business mo...

More Information about "SERI LUGANO" on BioPortfolio

We have published hundreds of SERI LUGANO news stories on BioPortfolio along with dozens of SERI LUGANO Clinical Trials and PubMed Articles about SERI LUGANO for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SERI LUGANO Companies in our database. You can also find out about relevant SERI LUGANO Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record